Serina Therapeutics, Inc. Annual Cost of Revenue in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Serina Therapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from 2017 to 2023.
  • Serina Therapeutics, Inc. Cost of Revenue for the quarter ending December 31, 2023 was $1K, unchanged year-over-year.
  • Serina Therapeutics, Inc. Cost of Revenue for the twelve months ending December 31, 2023 was $40K, a 208% increase year-over-year.
  • Serina Therapeutics, Inc. annual Cost of Revenue for 2023 was $40K, a 208% increase from 2022.
  • Serina Therapeutics, Inc. annual Cost of Revenue for 2022 was $13K, a 31.6% decline from 2021.
  • Serina Therapeutics, Inc. annual Cost of Revenue for 2021 was $19K, a 26.9% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $40K +$27K +208% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 $13K -$6K -31.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $19K -$7K -26.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $26K -$218K -89.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $244K -$120K -33% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $364K +$196K +117% Jan 1, 2018 Dec 31, 2018 10-K/A 2020-03-31
2017 $168K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.